The ROAD 2.0 to Sustainable Medication Use: Redispensing Unused Oral Anticancer Drugs

NARecruitingINTERVENTIONAL
Enrollment

2,500

Participants

Timeline

Start Date

January 10, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
CancerOncologyPharmacyDrug Prescriptions
Interventions
OTHER

redispensing oral anticancer drugs

"Participants will receive oral anticancer drugs according to their regular prescriptions, distributed in the original manufacturer's package. Following the guideline, some oral anticancer drug (i.e. requiring temperature storage up to 25C degrees) will be supplemented with a validated temperature indicator (Timestrip Neo, customer configuration), enclosed with a seal bag. Patients are requested to return unused oral anticancer drugs to the outpatient pharmacy that distributed them.~Pharmacy staff will assess the quality of returned oral anticancer drugs, applying the following criteria:~1. the seal bag is unopened~2. the drug package is unopend and undamaged~3. the expiry date is ≥ 3 months~4. the medication has not been stored outside the product label storage claim~Oral anticancer drugs that meet all criteria are restocked, and consecutively redispensed to participants visiting the same outpatient pharmacy."

Trial Locations (1)

6525 GA

RECRUITING

Radboudumc, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER